LOS ANGELES, Sept 12 (Reuters) - Billionaire investor Carl Icahn has raised his stake in biotechnology company Amylin Pharmaceuticals Inc to 7.33 percent, according to documents filed on Friday with the U.S. Securities and Exchange Commission.
LOS ANGELES, Sept 12 (Reuters) - Billionaire investor Carl Icahn has raised his stake in biotechnology company Amylin Pharmaceuticals Inc to 7.33 percent, according to documents filed on Friday with the U.S. Securities and Exchange Commission.
